What is BlossomHill Therapeutics, Inc.'s annual revenue?

BlossomHill Therapeutics, Inc. (BLSM) reported annual revenue of $0 in its most recent fiscal year.

What is BlossomHill Therapeutics, Inc.'s net profit?

BlossomHill Therapeutics, Inc. (BLSM) reported net profit of $-61.0M in its most recent fiscal year.

What is BLSM EV/EBITDA?

BlossomHill Therapeutics, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -5.52.

NASDAQ · Financial Statements

BlossomHill Therapeutics, Inc. (BLSM) Financial Statements

$17.48 NASDAQ: BLSM Market Cap $508.34M

BlossomHill Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-61.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2024	2025
Revenue	$0	$0
Operating Profit	$-36.0M	$-64.0M
Net Profit	$-31.0M	$-61.0M
EPS	$-1.06	$-2.08
Op Margin	—	—

Balance Sheet (USD)

Metric	2024	2025
Total Assets	$107.0M	$163.0M
Total Liabilities	$180.0M	$295.0M
Cash	$100.0M	$137.0M
Borrowings	$1.0M	$22.0M

Cash Flow (USD)

Metric	2024	2025
Operating Cash Flow	$-31.0M	$-47.0M
Investing Cash Flow	$0	$-2.0M
Financing Cash Flow	$0	$1.0M
Net Cash Flow	$-14.0M	$37.0M
Free Cash Flow	$-32.0M	$-48.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.02
EV / EBITDA	-5.52
FCF Yield	-9.44%
Quick Ratio	8.97
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

BLSM Overview BLSM Dividend Run Stock Screener